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1. Introduction 
Adenosine 3’,5’-cyclic monophosphate (cyclic 
AMP) is recognized to be the intracellular mediator 
of several hormones [ 11. In the perinatal rat, cyclic 
AMP has been implicated in the control of synthesis 
of hepatic tyrosine aminotransferase and phospho- 
pyruvate carboxylase [2-51. Results from this labo- 
ratory suggest hat the induction of the two enzymes 
is triggered by an increase in the intracellular concen- 
tration of cyclic AMP [S]. Increases in cyclic AMP 
concentration in the liver during the perinatal period 
have been demonstrated [S-7] which preceded or 
were coincident with the increases in the activities of 
the two enzymes [5,7-91. In addition, it appears that 
a critical concentration of cylic AMP must be reached 
for effects on enzyme synthesis to occur [S]. 
In this report we present evidence of a positive 
significant correlation between the cyclic AMP con- 
centration and the activity of tyrosine aminotrans- 
ferase and phosphopyruvate carboxylase in the livers 
of newborn rats. The results support the hypothesis 
that cylic AMPis an important factor in the induction 
of the two enzymes in the perinatal rat in vivo. 
2. Experimental 
Progesterone was purchased from Oragon Labora- 
tories Ltd., Crown House, Morden, England. All other 
chemicals and biochemicals were as in [5,8]. Perinatal 
rats of the Wistar albino strain of Rattus nonvegicus 
of known gestation [8] were used. Gestation of this 
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colony is 22 days. Gestation was prolonged by pro- 
gesterone injection to the dam (2.5 mg progesterone 
in 0.1 ml peanut oil every 12 h) beginning on day 2 1 
of gestation and continuing until the animals were 
killed. Newborn animals were delivered by uterine 
section after decapitation of the dam [8]. Cyclic AMP 
was determined in individual livers as in [5]. Tyrosine 
aminotransferase and phosphopyruvate carboxylase 
activities were determined as in [8] in portions of the 
same liver supernatant. 
3. Results and discussion 
The concentration of cyclic AMP and the activities 
of tyrosine aminotransferase and phosphopyruvate 
carboxylase were measured at 1 h intervals in the 
livers of newborn rats delivered surgically during the 
last 3 days of gestation and during artificially prolonged 
gestation. The results are reported in fig.1. Enzyme 
activity is expressed as a function of the hepatic cyclic 
AMP concentration in vivo. Regression analyses of the 
enzyme activity and the cyclic AMP concentration at 
O-5 h after delivery on day 20-23 of gestation yielded 
positive significant correlations between the tyrosine 
aminotransferase activity and th.e cyclic AMP concen- 
tration(fig.lA)(r=0.85,p<O.OOl)and betweenthe 
phosphopyruvate carboxylase activity and the cyclic 
AMP concentration (fig.lB) (r = 0.88, p < 0.001). 
In each case the relationship between enzyme activity 
and cyclic AMP concentration was exponential. The 
synthesis of the two enzymes both in the liver of 
neonatal rats in vivo [24,10] and in foetal liver 
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explants in organ culture [ 11 ,121 appears to be 
induced following the administration of cyclic AMP 
or the hormones for which it is the intracellular effec 
tor. The results presented here, therefore, support 
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Fig.1. Correlation between enzyme activity and cyclic AMP 
concentration in the liver of perinatal rats. Foetal rats on days 
20-23 of gestation were delivered by uterine section after 
decapitation of the dam and maintained in the humidicrib 
under a stream of carbogen (95% 0,:5% CO,) at 37°C. The 
newborn rats were killed at hourly intervals up to 5 h after 
delivery and their livers were collected and treated as in 
section 2 for cyclic AMP or enzyme assay. (a) Correlation 
between tyrosine aminotransferase activity (rmol p-hydroxy- 
phenylpyruvate formed at 37”C/h/g liver) and cyclic AMP 
concentration. (b) Correlation between phosphopyruvate 
carboxylase activity (pm01 oxaloacetate formed at 37”C/h/g 
liver) and cyclic AMP concentration. Insets: The log of enzyme 
activity is plotted as a function of the cyclic AMP concen- 
tration. All lines were fitted by the least squares method. The 
concentration of cyclic AMP and the activities of the enzymes 
were determined in different liver samples. Each point is the 
mean * SEM of at least 4 determinations. 
the hypothesis that cyclic AMP is an important fac- 
tor in the induction of tyrosine aminotransferase and 
phosphopyruvate carboxylase activities in the peri- 
natal rat in vivo. 
The results presented in fig.1 suggest hat the 
activities of tyrosine aminotransferase and phospho- 
pyruvate carboxylase develop when the total liver 
concentration of cyclic AMP increases to 1 pmol/mg 
tissue or more. This occurs in utero during the last 
day of gestation and within l-2 h of surgical delivery 
of preterm foetuses [5]. However, once this concen- 
tration is reached, large increases in enzyme activity 
are associated with relatively small changes in cyclic 
AMP concentration (fig.1). These observations 
confirm that a critical concentration of cyclic AMP 
must be reached for the cyclic nucleotide to have 
its effects. 
According to the concept in [ 131, cyclic AMP- 
mediated effects of hormones in mammalian tissues 
come about by an activation of cyclic AMP-dependent 
protein kinases which mediate the phosphorylation 
of specific proteins, thereby modifying their biological 
activities. In the activation process, cyclic AMP pro- 
motes the dissociation of the inactive enzyme yielding 
the catalytically-active free subunit, while the cyclic 
nucleotide is bound to the regulatory subunit [ 14,151. 
The activation of protein kinase is the only well- 
documented mechanism of action of cyclic AMP in 
mammalian cells [ 161. This mechanism of action of 
cyclic AMP has also been implicated in the control 
of tyrosine aminotransferase and phosphopyruvate 
carboxylase synthesis in rat liver [ 17,181. In addi- 
tion, a direct effect of cyclic AMP on the release of 
tyrosine aminotransferase from polysomes has been 
proposed [ 19,201, which does not involve protein 
kinase but requires a microsomal extract which has 
been identified as a protein which binds cyclic AMP 
with high affinity [21]. 
Studies on the interaction of cyclic AMP with the 
receptor protein in the activation of protein kinase in 
the rat liver in vivo [22] have shown that an increase 
in the total tissue concentration of cyclic AMP from 
0.7-l .2 pmol/mg liver is required for half-maximal 
activation of protein kinase as well as half-maximal 
binding of cyclic AMP to the receptor protein. The 
results presented in fig.1 suggest hat the induction 
of tyrosine aminotransferase and phosphopyruvate 
carboxylase in the perinatal rat liver in vivo is asso- 
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ciated with similar increases in the hepatic cyclic 
AMP concentration. These observations suggest hat 
the binding of cyclic AMP to the receptor protein 
or the activation of protein kinase may be an impor- 
tant step in the physiological mechanism for enzyme 
induction by cyclic AMP in the perinatal rat. 
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